Methoxy arachidonyl fluorophosphonate

From WikiMD's WELLNESSPEDIA

Methoxy arachidonyl fluorophosphonate (MAFP) is a potent and irreversible inhibitor of several key enzymes in the metabolism of fatty acids, including phospholipase A2, fatty acid amide hydrolase (FAAH), and monoacylglycerol lipase (MAGL). It is often used in biochemical research to study the role of these enzymes in physiological and pathological processes.

Chemical Structure[edit]

MAFP is a fluorophosphonate, a class of compounds characterized by a phosphorus-fluorine bond. This bond is highly reactive, allowing MAFP to bind covalently to the active site of target enzymes, thereby inhibiting their activity. The methoxy arachidonyl moiety of MAFP is a long-chain polyunsaturated fatty acid, which allows the compound to interact with lipid substrates and membranes.

Mechanism of Action[edit]

MAFP acts by binding irreversibly to the active site of its target enzymes. The fluorophosphonate group reacts with a serine residue in the active site, forming a covalent bond that permanently blocks the enzyme's activity. This mechanism is similar to that of other serine hydrolase inhibitors, such as diisopropyl fluorophosphate (DFP) and sarin.

Biological Effects[edit]

The inhibition of phospholipase A2, FAAH, and MAGL by MAFP has profound effects on the metabolism of fatty acids. These enzymes are involved in the production and degradation of various lipid mediators, including eicosanoids and endocannabinoids. By inhibiting these enzymes, MAFP can alter the levels of these mediators, affecting a wide range of physiological processes, such as inflammation, pain perception, and neurotransmission.

Research Applications[edit]

MAFP is widely used in biochemical research to study the role of phospholipase A2, FAAH, and MAGL in health and disease. For example, it has been used to investigate the role of endocannabinoids in neuropsychiatric disorders, the involvement of eicosanoids in inflammation and cancer, and the function of lipid mediators in cell signaling.

Safety[edit]

As an irreversible inhibitor of key metabolic enzymes, MAFP can have toxic effects. It should be handled with care, using appropriate safety measures to avoid exposure.

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.